Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00839631 · ClinicalTrials.gov registry record · Phase 1
Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors
A Phase 1 study, sponsored by Dendreon.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT00839631 is a Phase 1 study that has completed, run by Dendreon. The registered enrollment target is 23 participants.
The verdict
NCT00839631, a Phase 1 study, has completed, sponsored by Dendreon.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
This is a Phase 1, dose escalation study evaluating safety and pharmacokinetics of enteric coated D-3263 HCl in subjects with advanced solid tumors
Interventions
- DRUG EC D-3263 HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2009-03 |
| Est. Completion | 2012-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00839631
The ClinicalTrials.gov registry entry for NCT00839631 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dendreon, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EC D-3263 HCl is the first listed.
NCT00839631 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00839631 about?
NCT00839631 is a clinical study titled "Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors". This is a Phase 1, dose escalation study evaluating safety and pharmacokinetics of enteric coated D-3263 HCl in subjects with advanced solid tumors
What is the current status of trial NCT00839631?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2009-03. Estimated completion is 2012-04.
What interventions are being tested in trial NCT00839631?
The interventions under investigation include: EC D-3263 HCl (DRUG).
Who is sponsoring clinical trial NCT00839631?
This trial is sponsored by Dendreon, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.